Bictegravir/emtricitabine/tenofovir-alafenamide/mirtazapineLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2050卷 / 1期

关键词：

D O I：

10.1007/s40278-025-79085-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：115 / 115

相关论文

共 50 条

[1] Bictegravir/emtricitabine/tenofovir-alafenamide/doxycyclineLack of efficacy
Reactions Weekly, 2024, 2006 (1) : 142 - 142
[2] Bictegravir/emtricitabine/tenofovir-alafenamide/hydrochlorothiazideVarious toxicities
Reactions Weekly, 2023, 1984 (1) : 113 - 113
[3] Bictegravir/emtricitabine/tenofovir-alafenamide/glucoseFanconi syndrome and refeeding syndrome: case report
Reactions Weekly, 2023, 1980 (1) : 90 - 90
[4] Bictegravir/emtricitabine/tenofovir-alafenamide/lenacapavirResistance and poor adherence.: case report
Reactions Weekly, 2024, 2024 (1) : 96 - 96
[5] Bictegravir/emtricitabine/tenofovir-alafenamide/Epinephrine/VoriconazoleDisseminated histoplasmosis with gastrointestinal bleeding and lack of efficacy : case report
Reactions Weekly, 2024, 2020 (1) : 102 - 102
[6] Bictegravir/emtricitabine/tenofovir-alafenamide/Doravirine/lamivudine/tenofovir-disoproxil-fumarateWeight increased and lack of efficacy: case report
Reactions Weekly, 2024, 2025 (1) : 89 - 89
[7] Bictegravir/emtricitabine/tenofovir-alafenamide/cobicistat/darunavir/emtricitabine/tenofovir-alafenamideHyperglycaemia and gastrointestinal side effects: case report
Reactions Weekly, 2024, 2039 (1) : 107 - 107
[8] Bictegravir/emtricitabine/tenofovir-alafenamide/levothyroxine-sodiumPretibial myxedema associated with hyperthyroidism: case report
Reactions Weekly, 2023, 1962 (1) : 98 - 98
[9] Bictegravir/emtricitabine/tenofovir-alafenamide/raltegravirAcquired resistance and treatment non compliance
Reactions Weekly, 2024, 2011 (1) : 92 - 92
[10] Bictegravir/emtricitabine/tenofovir alafenamide
不详
AUSTRALIAN PRESCRIBER, 2019, 42 (02) : 68 - 69

← 1 2 3 4 5 →